Compassionate Use (CU) of REGN5458 for Patients With Relapsed or Refractory Multiple Myeloma (MM)

Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors

NCT05480644 ·Status: RECRUITING

CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice

NCT02900248 ·Status: TERMINATED

Studying Gene Expression in Samples From Patients With Rhabdoid Tumors

NCT01553175 ·Status: COMPLETED

Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia

NCT01057095 ·Status: COMPLETED

Studying Biomarkers in Samples From Younger Patients With Kidney Cancer

NCT01642095 ·Status: WITHDRAWN

Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma

NCT01365962 ·Status: COMPLETED

Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma

NCT00991991 ·Status: TERMINATED

Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy

NCT05112627 ·Status: COMPLETED

Detection of CSF Next Generation Sequencing in the Application of Brain Metastases From Lung Adenocarcinoma or Meningeal Metastasis

NCT03029065 ·Status: UNKNOWN

Collection of Cerebrospinal Fluid and Tumor Tissue in Subjects With Metastatic Melanoma and Controls

NCT01312506 ·Status: WITHDRAWN

Biomolecular Analysis for Predicting Response to Regorafenib

NCT05759195 ·Status: COMPLETED ·Phase: NA

Transcriptomics and Epigenetics Analysis in Drug-Resistance of Multiple Myeloma

NCT05888636 ·Status: RECRUITING

Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile

NCT01454297 ·Status: COMPLETED

Evaluation of the Humoral and Tumoral Molecular Alteration Profile of Brain Metastases

NCT05848050 ·Status: COMPLETED ·Phase: NA

Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities

NCT04314752 ·Status: RECRUITING

Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative

NCT05556642 ·Status: RECRUITING

Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma

NCT01689766 ·Status: COMPLETED ·Phase: PHASE2

Rare CNS Tumors Outcomes &Risk

NCT03251989 ·Status: COMPLETED

DNA Tests in Detecting Disseminated Disease in Tumor, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma

NCT01419509 ·Status: COMPLETED

Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer

NCT00918658 ·Status: TERMINATED

CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases

NCT02058953 ·Status: COMPLETED

Study of Blood and Cheek Cell Samples From Patients With Glioma

NCT01009307 ·Status: COMPLETED

Studying Genes in Samples From Younger Patients With Rhabdomyosarcoma

NCT01585376 ·Status: COMPLETED

Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye

NCT00952939 ·Status: COMPLETED

Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy

NCT01543100 ·Status: COMPLETED ·Phase: NA